Conference: Dutch Medicines Days
Date: October 8 - 9, 2025
Location: Corpus Congress Centre Leiden, Netherlands
Meet us there
Li Qin, Director of Consulting at Certara, will be attending the conference and presenting the poster on behalf of the team on Wednesday and Thursday, October 8–9, from 12:45–2:00 PM.
Li looks forward to connecting with peers and sharing how #MBMA continues to shape model-informed decision making in pharmaceutical development.
Where to hear Certara insights and Expertise
Authors: by Li Qin, Paul Matthias Diderichsen, Matt Zierhut,
The poster highlights how Model-Based Meta-Analysis (MBMA) integrates data across multiple clinical trials to quantify treatment efficacy, predict outcomes for new drug combinations, and inform go/no-go and portfolio-level decisions across the drug development lifecycle.
